A new pharmacological agent to treat glioblastoma multiforme has been developed by researchers.
Glioblastoma Multiforme | Astrocytoma Grade 4 - Types, Causes, Symptoms, Diagnosis, Treatment
Glioblastomas are tumors that arise from astrocytes that make up the supportive tissue of the brain. Glioblastomas are usually highly malignant.
Glioblastomas are tumors that arise from astrocytes that make up the supportive tissue of the brain. Glioblastomas are usually highly malignant.
‘The newly developed pharmacological agent could - with additional chemistry - lead to a new drug to prevent radiation-induced invasion of glioblastoma multiforme cells.’
Paul B. Fisher, Director of the Virginia Commonwealth
University's (VCU) Institute of Molecular Medicine (VIMM), focuses on
cancer genetics and Web Cavenee, Director of the Ludwig Institute
for Cancer Research at the University of California at San Diego focuses
on GBM. An exciting breakthrough for the treatment of GBM, this is about collaboration between two scientists on opposite coasts and shows how NFCR research may lead to tangible therapies for multiple cancers.
NFCR has been funding Dr. Fisher's research since 2008, and Dr. Cavenee's research starting in 2002.
5-ALA Fluorescence Guides Resection of Recurrent Glioblastoma Multiforme: Scientists
The use of 5-aminolevulinic acid (5-ALA) fluorescence in guiding resection of recurrent glioblastoma multiforme (GBM) was described by neurosurgeons from UC San Francisco.
The use of 5-aminolevulinic acid (5-ALA) fluorescence in guiding resection of recurrent glioblastoma multiforme (GBM) was described by neurosurgeons from UC San Francisco.
Source-Eurekalert
Cell Maturity Pathway is Deleted or Weak in Glioblastoma Multiforme: Scientists
Scientists report that a program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor.
Scientists report that a program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor.
Researchers Identify Drug To Halt The Spread Of Deadly Brain Tumors
The drug, propentofylline or PPF, limits the spread of glioblastoma multiforme, a common primary tumor of the brain and central nervous system by targeting a protein called TROY.
The drug, propentofylline or PPF, limits the spread of glioblastoma multiforme, a common primary tumor of the brain and central nervous system by targeting a protein called TROY.
